IL-6 is a contextually useful biomarker in pediatric oncological patients with febrile illness, with demonstrated value in early infection detection (e.g., Tapia et al. (2021) [6]: AUC = 0.743) and risk stratification. The gene discussed is IL6; the disease is infection.